Back

Phosphodiesterases: do we need atrial selective Viagra?

29 August 2017 (17:15 - 17:37)
Organised by:
Congress Presentation Part of: Novel molecular targets in atrial fibrillation Ion channels and electrophysiology ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Cristina Molina

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

3 More presentations in this session

Presentation thumbnail
Atrial selective potassium channels: novel drug targets?
Professor C. Schmidt (Goettingen, DE)
Presentation thumbnail
Targeting ion-channel trafficking: a novel therapeutic approach?
Doctor E. Balse (Paris, FR)
Slides Video
Presentation thumbnail
MicroRNAs: biomarker or therapeutic target in atrial fibrillation?
Doctor S. Reilly (Oxford, GB)
Slides Video

Access the full session

Session thumbnail
Novel molecular targets in atrial fibrillation

The Event

Event poster

ESC Congress 2017

29 August 2017 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Role of phosphodiesterases in the development of takotsubo syndrome
1 September 2020
thumbnail
Congress Presentation
Erectile dysfunction: the antenna of cardiovascular disease!
26 April 2024
thumbnail
Congress Presentation
Safety and efficacy of sildenafil in patients with advanced heart failure.
22 May 2023
thumbnail
Webinar
Focus on percutaneous short-term ventricular assist devices: joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices - Part 3. PVAD in right and biventricular failure
8 March 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources